Claypoole Robert E has filed 15 insider transactions across 1 company since January 2024.
Most recent transaction: a option exercise of 33500 shares of Bioventus Inc. ($BVS) on March 13, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 13, 2026 | Bioventus Inc. | $BVS | Claypoole Robert E | President and CEO | M | Class A Common Stock | 33500 | $0.00 | 150,497.0000 | 68,837,797 | 28.63% | 0.05% |
| March 13, 2026 | Bioventus Inc. | $BVS | Claypoole Robert E | President and CEO | F | Class A Common Stock | 14553 | $8.62 | 135,944.0000 | 68,837,797 | 9.67% | 0.02% |
| March 14, 2025 | Bioventus Inc. | $BVS | Claypoole Robert E | President and CEO | A | Restricted Stock Units | 134000 | $0.00 | 134,000.0000 | 64,547,474 | 9999.99% | 0.21% |
| March 14, 2025 | Bioventus Inc. | $BVS | Claypoole Robert E | President and CEO | A | Stock Option (Right to Buy) | 153000 | $0.00 | 153,000.0000 | 64,547,474 | 9999.99% | 0.24% |
| March 13, 2026 | Bioventus Inc. | $BVS | Claypoole Robert E | President and CEO | A | Restricted Stock Units | 278000 | $0.00 | 278,000.0000 | 68,837,797 | 9999.99% | 0.40% |
| March 13, 2026 | Bioventus Inc. | $BVS | Claypoole Robert E | President and CEO | A | Stock Option (Right to Buy) | 309000 | $0.00 | 309,000.0000 | 68,837,797 | 9999.99% | 0.45% |
| March 13, 2026 | Bioventus Inc. | $BVS | Claypoole Robert E | President and CEO | M | Restricted Stock Units | 33500 | $0.00 | 100,500.0000 | 68,837,797 | 25.00% | 0.05% |
| Jan. 9, 2026 | Bioventus Inc. | $BVS | Claypoole Robert E | President and CEO | M | Restricted Stock Units | 93750 | $0.00 | 187,500.0000 | 68,837,797 | 33.33% | 0.14% |
| Jan. 9, 2026 | Bioventus Inc. | $BVS | Claypoole Robert E | President and CEO | M | Class A Common Stock | 93750 | $0.00 | 158,714.0000 | 68,837,797 | 144.31% | 0.14% |
| Jan. 9, 2026 | Bioventus Inc. | $BVS | Claypoole Robert E | President and CEO | F | Class A Common Stock | 41717 | $8.03 | 116,997.0000 | 68,837,797 | 26.28% | 0.06% |
| Jan. 13, 2025 | Bioventus Inc. | $BVS | Claypoole Robert E | President and CEO | S | Class A Common Stock | 28786 | $9.10 | 64,964.0000 | 64,547,474 | 30.71% | 0.04% |
| Jan. 10, 2025 | Bioventus Inc. | $BVS | Claypoole Robert E | President and CEO | M | Class A Common Stock | 93750 | $0.00 | 93,750.0000 | 64,547,474 | 9999.99% | 0.15% |
| Jan. 10, 2025 | Bioventus Inc. | $BVS | Claypoole Robert E | President and CEO | M | Restricted Stock Units | 93750 | $0.00 | 281,250.0000 | 64,547,474 | 25.00% | 0.15% |
| Jan. 11, 2024 | Bioventus Inc. | $BVS | Claypoole Robert E | President and CEO | A | Restricted Stock Units | 375000 | $0.00 | 375,000.0000 | 62,647,554 | 9999.99% | 0.60% |
| Jan. 11, 2024 | Bioventus Inc. | $BVS | Claypoole Robert E | President and CEO | A | Stock Option (Right to Buy) | 850000 | $0.00 | 850,000.0000 | 62,647,554 | 9999.99% | 1.36% |